BC-LI-0186
BC-LI-0186 is a potent, selective inhibitor of the LRS-RagD interaction with a Kd of 42.1 nM. It suppresses mTORC1 signaling by this mechanism, inhibiting the growth of rapamycin-resistant cancer cells in vitro, and is applied in lung cancer research.
Product Specifications
CAS Number
695207-56-8
Product Name Alternative
Inhibitor, leucyl-tRNA synthetase, Leucyl-tRNA synthetase, H460, lung cancer, KRAS G12D, inhibit, A549, 4- (2,3-dimethyl-5-oxo-4-propan-2-ylpyrazol-1-yl) -N- (2-phenoxyethyl) benzenesulfonamide, BC LI 0186, BC-LI 0186, BCLI0186, BC-LI0186, BC-LI-0186, Aminoacyl-tRNA Synthetase, RagD, rapamycin-resistant, Ras-related GTP-binding protein D (RagD), tRNA Synthetase, aaRS
Purity
99.17% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (9.31 mM) ; DMSO:100 mg/mL (232.81 mM)
Smiles
CC (C) c1c (C) n (C) n (-c2ccc (cc2) S (=O) (=O) NCCOc2ccccc2) c1=O
Molecular Formula
C22H27N3O4S
Molecular Weight
429.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV655536 1.0 µg DNA
B3GNT6 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 
MBS7270362-01 48 Well
Rabbit SH3 domain-binding glutamic acid-rich-like protein 3
Sign In for Pricing
View Details